Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
2020 · Scientific Reports · 68 citations
https://doi.org/10.1038/s41598-020-74761-y
B
Bo Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
967
Citations
12
h-index
12
i10-index
Bo Wang is an academic researcher. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & SARS-CoV-2 and COVID-19 Research & Glycosylation and Glycoproteins Research. The author has an h-index of 12, co-authored 19 publications.
Papers by this author
worksRegulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen
2019 · mAbs · 61 citations
https://doi.org/10.1080/19420862.2019.1690959
First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants
2022 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-022-07952-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat